Parkman Healthcare Partners LLC Merck & Co., Inc. Transaction History

Parkman Healthcare Partners LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 12, 2021	SELL	$71.77 - $79.65 $9.03 Million - $10 Million	-125,834 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$73.18 - $82.95 $585 - $663	8 Added 0.01%	125,834 $10.4 Million
Q2 2020 Aug 13, 2020	SELL	$70.42 - $80.13 $6.34 Million - $7.21 Million	-90,000 Reduced 41.7%	125,826 $9.73 Million
Q1 2020 May 15, 2020	SELL	$63.36 - $87.82 $264,464 - $366,560	-4,174 Reduced 1.9%	215,826 $16.6 Million
Q4 2019 Feb 13, 2020	BUY	$77.58 - $87.54 $17.1 Million - $19.3 Million	220,000 New	220,000 $20 Million

3,824

1.88B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $261B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Parkman Healthcare Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Parkman Healthcare Partners LLC with notifications on news.